Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.

作者: Michelle W. Wong-Brown , Kelly A. Avery-Kiejda , Nikola A. Bowden , Rodney J. Scott

DOI: 10.1002/IJC.28361

关键词:

摘要: Triple-negative breast cancer (TNBC) is a tumour classification that defined by oestrogen receptor, progesterone receptor and human epidermal growth factor 2 negativity. TNBCs share similar gene expression profile to BRCA-mutated tumours, have been shown carry high proportion of BRCA mutations more adverse prognosis compared other types tumours. PALB2 has be moderate-penetrance susceptibility involved in the same DNA damage repair pathway as BRCA1 BRCA2; this raises possibility germline may pathogenesis TNBCs. In our study, we sequenced coding regions (including intron/exon boundaries) genomic from 347 patients diagnosed with TNBC determine prevalence deleterious population. Two novel truncating (c.758dup c.2390del) one previously detected mutation (c.3113+5G>C) were found. addition, five variants predicted protein-affecting also identified. Our study shows individuals ∼1%, 1% familial non-BRCA1/2 cohorts.

参考文章(47)
Florentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou, Maroulio Pertesi, Eleni Timotheadou, Alexandra V. Stavropoulou, Stavros Glentis, Evangelos Bournakis, Mattheos Bobos, Dimitrios Pectasides, Pavlos Papakostas, George Pentheroudakis, Helen Gogas, Pantelis Skarlos, Epaminontas Samantas, Dimitrios Bafaloukos, Paris A. Kosmidis, Angelos Koutras, Drakoulis Yannoukakos, Irene Konstantopoulou, George Fountzilas, Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study Breast Cancer Research and Treatment. ,vol. 134, pp. 353- 362 ,(2012) , 10.1007/S10549-012-2021-9
María J García, Victoria Fernández, Ana Osorio, Alicia Barroso, Gemma LLort, Conxi Lázaro, Ignacio Blanco, Trinidad Caldés, Miguel De la Hoya, Teresa Ramón y Cajal, Carmen Alonso, María-Isabel Tejada, Carlos San Román, Luis Robles-Díaz, Miguel Urioste, Javier Benítez, None, Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families Breast Cancer Research and Treatment. ,vol. 113, pp. 545- 551 ,(2009) , 10.1007/S10549-008-9945-0
Agnieszka Dansonka-Mieszkowska, Anna Kluska, Joanna Moes, Michalina Dabrowska, Dorota Nowakowska, Anna Niwinska, Pawel Derlatka, Krzysztof Cendrowski, Jolanta Kupryjanczyk, A novel germline PALB2 deletion in Polish breast and ovarian cancer patients BMC Medical Genetics. ,vol. 11, pp. 20- 20 ,(2010) , 10.1186/1471-2350-11-20
Rémi Buisson, Anne-Marie Dion-Côté, Yan Coulombe, Hélène Launay, Hong Cai, Alicja Z Stasiak, Andrzej Stasiak, Bing Xia, Jean-Yves Masson, Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination Nature Structural & Molecular Biology. ,vol. 17, pp. 1247- 1254 ,(2010) , 10.1038/NSMB.1915
Feng Zhang, Jianglin Ma, Jiaxue Wu, Lin Ye, Hong Cai, Bing Xia, Xiaochun Yu, PALB2 links BRCA1 and BRCA2 in the DNA-damage response Current Biology. ,vol. 19, pp. 524- 529 ,(2009) , 10.1016/J.CUB.2009.02.018
Natalia Bogdanova, Anna P. Sokolenko, Aglaya G. Iyevleva, Svetlana N. Abysheva, Magda Blaut, Michael Bremer, Hans Christiansen, Margret Rave-Fränk, Thilo Dörk, Evgeny N. Imyanitov, PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Research and Treatment. ,vol. 126, pp. 545- 550 ,(2011) , 10.1007/S10549-010-1290-4
Kirsi M Kuusisto, Aleksandra Bebel, Mauno Vihinen, Johanna Schleutker, Satu-Leena Sallinen, Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals Breast Cancer Research. ,vol. 13, pp. 1- 13 ,(2011) , 10.1186/BCR2832
Marc Tischkowitz, Bing Xia, PALB2/FANCN: Recombining Cancer and Fanconi Anemia Cancer Research. ,vol. 70, pp. 7353- 7359 ,(2010) , 10.1158/0008-5472.CAN-10-1012
Konstantin J. Dedes, Paul M. Wilkerson, Daniel Wetterskog, Britta Weigelt, Alan Ashworth, Jorge S. Reis-Filho, Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations Cell Cycle. ,vol. 10, pp. 1192- 1199 ,(2011) , 10.4161/CC.10.8.15273
Marc Tischkowitz, Bing Xia, Nelly Sabbaghian, Jorge S Reis-Filho, Nancy Hamel, Guilan Li, Erik H Van Beers, Lili Li, Tayma Khalil, Louise A Quenneville, Atilla Omeroglu, Aletta Poll, Pierre Lepage, Nora Wong, Petra M Nederlof, Alan Ashworth, Patricia N Tonin, Steven A Narod, David M Livingston, William D Foulkes, None, Analysis of PALB2/FANCN-associated breast cancer families Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 6788- 6793 ,(2007) , 10.1073/PNAS.0701724104